InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Goldberg Andrew D.. Insider active across 1 company, notably Tarsus Pharmaceuticals, Inc.. Aggregated, 5 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €17k. Activity tracked since 15 December 2023. The latest transaction was disclosed on 7 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Andrew D. Goldberg is a declarant linked to Tarsus Pharmaceuticals, Inc. (XNAS), where he is Director. The record shows 5 filings in total, and across the 5 recent filings tracked, the period runs from 2023-06-21 to 2025-06-16, with total buys of EUR 17246 and total sells of EUR 0, the most frequent transaction nature being option exercise.